Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-1971a in Diabetic Peripheral Neuropathic Pain
NCT02673866Phase 2Withdrawn
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of DS-1971 in diabetic polyneuropathy (DPN) (5 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Average Daily Pain Score at Week 7. Planned start Feb 2016; status: withdrawn.
02
Drugs
DS-1971
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT02673866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673866.